there is compelling rationale for extending the preliminary physiologic benefits of sildenafil seen in 'systolic' heart failure to the population with 'diastolic' heart failure. The RELAX trial ...
Joanne Matos, 37, was born with an enlarged heart and has congestive heart failure. Despite a stroke and two silent heart ...
The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...
GlobalData on MSN16d
FDA approves drug application for Lupin’s heart failure therapyThe approval covers dosages of 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg. They are also used for treating symptomatic heart failure with systemic left ventricular systolic dysfunction in paediatric ...
These findings support more aggressive blood pressure management for people with Type 2 diabetes to reduce their risk of ...
News Medical on MSN13d
Study highlights novel approaches to treating diabetic cardiomyopathyAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and ...
The blood pressure study could help doctors treating people with diabetes to reduce the risk of "major cardiovascular events" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback